Welcome

Sign out Have a question? We're here to help

Copyright © 2020 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Editas Medicine (EDIT)

$30.64 0.00 (0.00%)

9:10 EST EDIT Stock Quote Delayed 15 Minutes

Volume:

Previous Close $30.64

Market Cap 1.46B

PE Ratio -10.94

EPS -2.8

Volume (Avg. Vol.) 609

Day's Range 30.64 - 30.64

52-Week Range 19.00 - 34.37

Dividend & Yield N/A (N/A)

EDIT Stock Predictions, Articles, and Editas Medicine News

From InvestorPlace
From the Web

7 Biotech Stocks to Buy and Hold in 2020

By Chris Lau, InvestorPlace Contributor Dec 17, 2019

Biotech stocks pulled off an impressive rally to finish 2019 strong. These names in the industry are looking to do the same in 2020.

3 Biotech Stocks That Are Set for a Breakthrough

By Matt McCall, Editor, MoneyWire Feb 1, 2019

If you're looking for biotech stocks to buy with massive breakthrough potential in gene editing, then these three are kings among the rest.

Gene Editing is a Major Technology to Watch

By Matt McCall, Editor, MoneyWire Aug 27, 2018

Gene-editing technology is going to be a game-changer in the future, which means the time to invest in CRISPR stocks is now.

Whole Foods Market, Inc. (WFM) and Xtant Medical Holdings Inc (XTNT) Lead 13 Activist Investment Filings

By Fintel May 31, 2017

13G and 13D filings are windows into activist investor activity. Latest filings include Whole Foods Markets, Inc., and these 12 other stocks

The Daily Biotech Pulse: Osmotica Soars On Insider Buys, Ultragenyx's Partnered Rare Disease Drug Moves Into Clinics

From Benzinga Jan 16, 2020

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 15) 10X Genomics Inc (NASDAQ...

Notable Wednesday Option Activity: DIS, EDIT, FLNT

From Market News Video Jan 15, 2020

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Walt Disney Co. (DIS), where a total volume of 96,458 contracts has been traded thus far today, a contract volume which is representative of approximately 9.6 million underlying shares (given that every 1 contract represents 100 underlying shares)..

Stocks That Hit 52-Week Highs On Wednesday

From Benzinga Jan 15, 2020

On Wednesday, 277 companies set new 52-week highs. Noteworthy Points: NextEra Energy (NYSE: NEE) was the largest company by market cap to set a new 52-week high this...

The Daily Biotech Pulse: Nektar Withdraws Opioid Pain Drug NDA, Galapagos Takes Stake In Fibrocor, Integra Lifesciences Lowers Q4 Guidance

From Benzinga Jan 15, 2020

The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Jan. 14.) Adaptimmune...

Why This Biotech Stock Is Planning To Gene Edit Its Cancer Drugs

From Investor's Business Daily Jan 13, 2020

Shares of Iovance Biotherapeutics toppled Monday after the biotech company announced a gene-editing deal with Cellectis using TALEN technology.

Editas teams up with Sandhill Therapeutics in cancer; shares up 2% premarket

From Seeking Alpha Jan 13, 2020

Editas Medicine (NASDAQ:EDIT) perks up 2% premarket on light volume in reaction to its agreement with Sandhill Therapeutics aimed at discovering, developing and manufacturing allogeneic engineered nat

Navellier Ratings

Powered by Portfolio Grader

Total Grade

D

Sell